Compare SIRI & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SIRI | KYMR |
|---|---|---|
| Founded | 2013 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3B | 6.8B |
| IPO Year | 1996 | 2020 |
| Metric | SIRI | KYMR |
|---|---|---|
| Price | $22.43 | $74.30 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 26 |
| Target Price | $25.00 | ★ $107.72 |
| AVG Volume (30 Days) | ★ 3.3M | 622.7K |
| Earning Date | 04-30-2026 | 05-08-2026 |
| Dividend Yield | ★ 4.91% | N/A |
| EPS Growth | ★ 136.32 | N/A |
| EPS | ★ 2.23 | N/A |
| Revenue | ★ $5,425,129,000.00 | $39,211,000.00 |
| Revenue This Year | $1.81 | $16.05 |
| Revenue Next Year | $0.65 | $4.79 |
| P/E Ratio | $9.89 | ★ N/A |
| Revenue Growth | ★ 8.13 | N/A |
| 52 Week Low | $18.69 | $19.45 |
| 52 Week High | $24.55 | $103.00 |
| Indicator | SIRI | KYMR |
|---|---|---|
| Relative Strength Index (RSI) | 56.10 | 35.15 |
| Support Level | $22.02 | $64.95 |
| Resistance Level | $22.57 | $77.93 |
| Average True Range (ATR) | 0.49 | 3.66 |
| MACD | -0.02 | -1.19 |
| Stochastic Oscillator | 64.91 | 5.84 |
SiriusXM operates almost exclusively in the US through its SiriusXM and Pandora audio services. SiriusXM is primarily a satellite radio service that offers nationwide coverage and mostly ad-free listening, with proprietary channels and exclusive content. It makes agreements with automakers to install its radios in vehicles and give trial services to vehicle buyers, which have traditionally fed its subscriber base. The company provides the service via a fleet of geostationary satellites it owns and operates, and now offers a streaming SiriusXM option. Pandora, which accounts for a much smaller portion of revenue and profit, offers a subscription and ad-supported streaming music service that competes with industry giants such as Spotify, Apple Music, and YouTube Music.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.